Regeneron
Regeneron's Eylea HD and Libtayo gain FDA and EU approvals, respectively, sparking investment and job creation news. Meanwhile, Samsung Bioepis settles with Regeneron for a biosimilar launch, impacting market dynamics.
About Regeneron
Regeneron Pharmaceuticals is a biotechnology company focused on the discovery, development, and commercialization of medicines.
Insights
- regeneron engagements is up 34.73% from the previous week.
Engagements: [------] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +35%
[--] Month: [-------] -95%
[--] Months: [----------] +168%
[--] Year: [----------] +284%
1-Year High: [----------] on 2026-01-05
1-Year Low: [--] on 2025-09-07
Engagements by network (24h): Reddit: [---] X: [-----] Instagram: [-----] News: [--] YouTube: [------] TikTok: [-----]
Mentions: [---] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +2%
[--] Month: [-----] +4.80%
[--] Months: [-----] +40%
[--] Year: [-----] +113%
1-Year High: [---] on 2025-12-22
1-Year Low: [--] on 2025-09-07
Mentions by network (24h): Reddit: [--] X: [--] Instagram: [--] News: [--] YouTube: [---] TikTok: [--]
Creators: [---] (24h)
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Regeneron in the last [--] hours which is up 16% from [---] in the previous [--] hours
Daily Average: [---]
[--] Week: [---] -1.50%
[--] Month: [---] +11%
[--] Months: [-----] +22%
[--] Year: [-----] +129%
1-Year High: [---] on 2025-05-20
1-Year Low: [--] on 2025-09-07
The most influential creators that mention Regeneron in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @tunemusicalmoments | [--] | [---------] | [--] | [------] |
| @drsiyabmd | [--] | [-------] | [--] | [-----] |
| @regeneron | [--] | [------] | [--] | [-----] |
| @nataninvesting | [--] | [------] | [--] | [-----] |
| @laurenpcrna | [--] | [-------] | [--] | [---] |
| @okie_kim4.0 | [--] | [------] | [--] | [---] |
| @justinskycak | [--] | [------] | [--] | [--] |
| @laasyaacharya | [--] | [---] | [--] | [--] |
| @grok | [--] | [---------] | [--] | [--] |
| @tomonota | [--] | [------] | [--] | [--] |
Sentiment: 88%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 88%
Daily Average: 87%
[--] Week: 60% -29%
[--] Month: 86% -2%
[--] Months: 86% -5%
[--] Year: 86% -8%
1-Year High: 100% on 2025-02-17
1-Year Low: 22% on 2025-06-14
Most Supportive Themes:
- Positive News and Partnerships: (40%) Regeneron's recent FDA approvals for Eylea HD and the expansion of Libtayo in the EU are driving positive sentiment, alongside news of significant investment and job creation in New York.
- Innovation and Research: (20%) Mentions of Regeneron's scientific breakthroughs, such as the development of a cost-effective prosthetic arm by a Regeneron Science Talent Search finalist and advancements in genetic medicine, are generating interest.
Most Critical Themes:
- Market Performance Concerns: (25%) Some discussions touch upon Regeneron's stock fluctuations and past underperformance, though recent news of FDA approvals and investment may be counteracting this.
- Negative Sentiment and Criticism: (15%) A smaller portion of posts express negative sentiment, including criticism of the company or its products, though this appears to be outweighed by positive news.
Top Regeneron Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Dragonfly Capital - [--] Trade Ideas for Tuesday: Crowdstrike Murphy USA Netscout Regeneron and Scotts Miracle-Gro $CRWD $MUSA $NTCT $REGN $SMG https://dragonflycap.com/5-trade-ideas-for-tuesday-crowdstrike-murphy-usa-netscout-regeneron-and-scotts-miracle-gro/ https://dragonflycap.com/5-trade-ideas-for-tuesday-crowdstrike-murphy-usa-netscout-regeneron-and-scotts-miracle-gro/"
X Link @harmongreg 2026-02-16T17:43Z 51.2K followers, [---] engagements
"💰 Highest Paid CEOs in the World 💰 [--]. Elon Musk Tesla $23.5 billion [--]. Tim Cook Apple $770.5 million [--]. Jensen Huang NVIDIA $561 million [--]. Reed Hastings Netflix $453.5 million [--]. Leonard Schleifer Regeneron $452.9 million [--]. Marc Benioff Salesforce $439.4 million [--]. Satya Nadella Microsoft $309.4 million [--]. Robert A. Kotick Activision Blizzard $296.7 million [--]. Hock E. Tan Broadcom $288 million [--]. Sundar Pichai Google (Alphabet) $280 million [--]. Andy Jassy Amazon $245 million [--]. Jamie Dimon JPMorgan Chase $230 million [--]. Nikesh Arora Palo Alto Networks $200$150 million [--]. Shantanu"
X Link @Stat_Cult 2026-02-16T03:47Z 31.3K followers, 12.9K engagements
"Natan YTD: -6.7% S&P500 YTD: -0.1% TOTAL RETURNS (Jan 2022) Natan's portfolio: +108.2% *Benchmark: +36.3% S&P500: +51.8% MY POSITIONS: 18.6% Transmedics $TMDX 15.3% Pinduoduo $PDD 9.1% Alibaba $BABA 7.6% Regeneron $REGN 7.4% Procept BioRobotics $PRCT 7.0% Meta Platforms $META 6.3% Paypal $PYPL 6.3% Robinhood $HOOD 5.7% Wizz Air $WIZZ 5.1% B2gold $BTG 5.0% Moderna $MRNA 3.5% Monday $MNDY 1.8% Edwards Lifesciences $EW 1.3% Crispr Therapeutics $CRSP Follow me: @nataninvesting - - - - - - - - - - - - - - - - - - - * : - 70% - 30% ** . ' and all the ."
X Link @nataninvesting 2026-02-14T13:49Z 39.5K followers, 12.6K engagements
"Great news for $HROW 👀 Samsung Bioepis has signed a settlement and license agreement with Regeneron that allows the launch of OPUVIZ a biosimilar to Eylea in the U.S. starting January [----]. $HROW can now launch the product six months earlier than originally expected. A very important catalyst for the company as it works toward its mid-term targets. https://twitter.com/i/web/status/2022288654547206169 https://twitter.com/i/web/status/2022288654547206169"
X Link @mvcinvesting 2026-02-13T12:36Z 84.9K followers, 18.4K engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing